UPDATE: AstraZeneca Says Its Vaccine Needs "Additional Study" Read More
"Additional Study" Needed For AstraZeneca Vaccine Says CEO Read More
LONDON MARKET CLOSE: FTSE Trails Peers Amid Thanksgiving Profit Taking Read More
UPDATE: AstraZeneca-Oxford 90% Vaccine Score Only In Younger Age Group Read More
PRESS: Doubts Raised Over AstraZeneca-Oxford Vaccine Data - FT Read More
UPDATE: UK PM Johnson Warns It Will Take Months To Vaccinate All In Need Read More
LONDON MARKET CLOSE: FTSE Trails Peers As Vaccine Boost Wanes Read More
UK To Receive 19 Million AstraZeneca Vaccine Doses By Year End Read More
LONDON MARKET PRE-OPEN: AstraZeneca Covid Vaccine Up To 90% Effective Read More
Trials For AstraZeneca's Covid-19 Treatment Set To Begin In UK Read More
TOP NEWS: AstraZeneca Says New Dosing Of Imfinzi Approved In US Read More
LONDON MARKET MIDDAY: Vaccine Cheer Recedes As Lockdown Jitters Return Read More
UK TOP NEWS SUMMARY: Oxford-Astra Vaccine Encouraging In Older Adults Read More
LONDON MARKET OPEN: NY Restrictions And Japan Virus Alert Damp Spirits Read More
TOP NEWS: Oxford Vaccine Shows Strong Immune Response In Older Adults Read More
Irish Government Sets Up Taskforce To Oversee Rollout Of Vaccine Read More
UK BROKER RATINGS SUMMARY: Investec Cuts Barclays; Goldman Raises Next Read More
AstraZeneca's Tezepelumab Shows Meaningful Reduction In Asthma Attacks Read More
CSL Begins Manufacturing Of Astra's AZD1222 Covid-19 Vaccine Candidate Read More
UK BROKER RATINGS SUMMARY: Panmure Says Buy AVEVA, Hold RSA Read More
